Cross-disciplinary biotechnology research and analytics for demanding industry leaders
Meet The Team
Director of Research
Damitha is Director of Research at GT Research. He is an accomplished investor with a demonstrated record of excellence in research, investment management and asset allocation. He is currently ranked 1st out of 10,000 analysts over the last twelve months on SumZero, the world’s largest community of investment professionals working at hedge funds, mutual funds, and private equity funds. His investment ideas and market commentaries have also been featured on Reuters, MSN, and Seeking Alpha. Damitha holds a BSc from the University of Mary Washington and an MBA from Duke University.
Dr. Michael Francis
Chief Science Officer
Dr. Francis is Chief Science Officer at GT Research and Assistant Professor of Physiology and Cell Biology at the University of South Alabama. Dr. Francis is an experienced research scientist with extensive knowledge of molecular biology, research processes and biomedical software and analytics. In addition to participating in Fund management, due diligence and investment decisions, Dr. Francis manages GTV Capital’s proprietary bioinformatics and genomics research platform. Dr. Francis earned a BSc in Physics from Auburn University and a PhD in Physiology from the University of South Alabama.
Chief Marketing Officer
Anthony Campbell is CMO and Managing Director at GT Research, ensuring a best-in-class experience for all GT Research clients. Anthony is well positioned to ensure the firm is ready to react to strategic growth opportunities in the health and wellness space. He brings a wealth of management consulting experience and expertise in global health sector management. Prior to joining GTV Capital, Anthony led product development and strategy formulations for top players in the global CPG industry from bench to shelf. Anthony holds a BSE in Chemical Engineering from the University of Michigan and an MBA from Duke University, The Fuqua School of Business, with a concentration in Health Sector Management.
Chief Executive Officer
Sam is Founder and CEO of GTR. He is also Co-Founder of Genesis Block, a blockchain- focused venture production studio. Prior to founding GTR, Sam was an attorney at Debevoise & Plimpton LLP, where he focused his practice on complex financial services regulation. Sam holds a JD from the University of Chicago Law School and a BSE from the Wharton School of the University of Pennsylvania, where he was a Benjamin Franklin Scholar and a Joseph Wharton Scholar.
David X. Liu
Chief Operating Officer
David is a distinguished strategy consultant and engineering specialist. He managed over $1 billion in assets at Morgan Stanley Investment Management and launched new industry, company, and stock coverage of oilfield equipment vertical valued at over $40 billion market capitalization.Recently he managed finance operations and developed and automated reporting and forecasting tools for Tesla. David holds a BSE, Wharton School & BA, University of Pennsylvania; MBA, University of California Berkeley.
Chief Growth Officer
A long-time investment practitioner and horticulturalist, Danny handles operations, project management, and execution for GTR. His professional experience includes oversight and execution of complex environmental and construction projects. Danny has overseen all aspects of crop production and sale on multi-acre organic farms in California and Montana. He holds a BA in Government and Law and a BA in Spanish from Lafayette College.